$UNH INSIGHTS →UnitedHealth Group subsidiaries OptumRx and Emisar Pharma Services have reached a proposed settlement with the Federal Trade Commission over alleged anti-competitive insulin rebate practices.
Read the full research in the app
A subscription is required to access the full thread.
Open in the app →